VIGI seeks to track the performance of the S&P Global Ex-U.S. Dividend Growers Index, a benchmark of large- and mid-cap companies headquartered outside the United States that have increased their annual dividends for at least seven consecutive years. The fund uses a full-replication, passive strategy and carries an expense ratio of 0.07%, among the lowest in its category.
The portfolio holds roughly 340 to 385 stocks depending on the reporting date, with assets under management (AUM) of approximately $9 billion. Its largest positions include Mitsubishi UFJ Financial Group, Royal Bank of Canada, SAP, Nestlé, Toronto-Dominion Bank, Novartis, Roche Holding, Schneider Electric, Sumitomo Mitsui Financial Group, Hitachi, and Novo Nordisk. I also checked this using Tickeron’s AI Screener to compare sector exposures across similar international funds.
By sector, financials represent close to 30% of the portfolio, followed by industrials (roughly 17%), healthcare (about 14%), and technology (about 12%). Consumer staples, consumer discretionary, and utilities round out meaningful smaller allocations. Geographically, Japan accounts for roughly one-third of assets, Canada about one-fifth, and Switzerland a meaningful share, with Germany and the United Kingdom also notable. This structure ties the fund closely to dividend-paying banks, insurers, pharmaceutical leaders, and industrial multinationals.
International equities have been shaped by several durable forces. Financials, the fund's largest sector exposure, remain sensitive to global yield curves, credit conditions, and central-bank policy. Japanese banks and Canadian lenders, both prominent in VIGI, benefit from relatively stable earnings profiles and shareholder-return programs, while European industrials and technology names such as SAP and Schneider Electric are tied to corporate capital spending and digitalization.
The healthcare complex, including Novartis, Roche, and Novo Nordisk, is influenced by drug pipelines, regulatory decisions, and demographic demand. Meanwhile, a stronger or weaker U.S. dollar can meaningfully affect returns for U.S.-based investors, since unhedged foreign-currency exposure is part of the fund's profile. Inflation trends and monetary policy across the Bank of Japan, European Central Bank, Bank of Canada, and Swiss National Bank are central to the macro backdrop for these holdings. From what I see, monitoring these policy shifts remains essential.
In recent weeks, VIGI has traded within a relatively narrow range, gradually drifting higher. Over the latest 30-day window, the fund advanced by roughly 4.7%, a moderate move driven less by a single catalyst than by broad, steady gains across its diversified holdings. The prior several weeks showed choppier, range-bound action, reflecting mixed signals from global bond yields and currency markets.
The fund's tilt toward financials and industrials has kept it sensitive to interest-rate expectations, while its quality bias has provided a degree of ballast during periods of uncertainty. Holdings such as Royal Bank of Canada, Toronto-Dominion Bank, and Mitsubishi UFJ contribute meaningful earnings stability, while technology and industrial names add growth characteristics. Because VIGI screens for sustained dividend growth rather than the highest yields, its portfolio skews toward companies with resilient cash flows and disciplined balance sheets.
Several structural factors are likely to shape VIGI during 2026. Central-bank policy in Japan, Europe, and Canada will remain pivotal, given the fund's heavy financials weighting and the sensitivity of bank net interest margins to rate levels. Currency movements, particularly the yen, euro, and Swiss franc versus the U.S. dollar, could amplify or dampen total returns for U.S.-based holders.
Corporate earnings across the healthcare and technology segments will be closely watched, as pharmaceutical pipeline developments and enterprise software demand influence major holdings. Global trade policy and industrial capital expenditure cycles may affect the fund's industrials sleeve. Finally, valuation dispersion between U.S. and international equities, along with investor rotation into dividend-growth strategies, could influence capital flows into international funds. These themes present both opportunities and risks that warrant ongoing monitoring. I’m watching this closely as the year progresses.
In my view, integrating AI-driven platforms has become a practical part of staying on top of funds like VIGI. Tickeron’s AI Trend Prediction Engine helps me evaluate potential momentum shifts across international equities without relying solely on manual charts. It provides another layer of perspective when assessing how holdings might respond to rate changes or currency moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The 10-day moving average for VIGI crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on VIGI as a result. In 72 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for VIGI just turned positive on October 13, 2026. Looking at past instances where VIGI's MACD turned positive, the stock continued to rise in 37 of 46 cases over the following month. The odds of a continued upward trend are 80%.
VIGI moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIGI advanced for three days, in 240 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 211 of 266 cases where VIGI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The 10-day RSI Indicator for VIGI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 28 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 62 cases where VIGI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIGI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
VIGI broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows